Ben Leonard
Optometrist · Calvert City, KYNPI 1306191218
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 97.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $25,487 and has fallen 54.1% since, to $11,702 in 2025. Among optometrist clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $564.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$73K
- Bausch & Lomb Americas Inc.$505
- Alcon$477
- Genentech USA, Inc.$147
- Apellis Pharmaceuticals, Inc.$145
- Shire North American Group Inc$140
- plus $555 from 7 others
What the payments were for
- Consulting fees$3,1404%
- Speaking & faculty fees$41,29055%
- Travel & lodging$24,36933%
- Food & beverage$5,7468%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 110 | $72,596 |
| Bausch & Lomb Americas Inc. | 6 | $505 |
| Alcon | 5 | $477 |
| Genentech USA, Inc. | 1 | $147 |
| Apellis Pharmaceuticals, Inc. | 1 | $145 |
| Shire North American Group Inc | 2 | $140 |
| Harrow Eye, LLC | 1 | $123 |
| Sun Pharmaceutical Industries Inc. | 1 | $115 |
| Aerie Pharmaceuticals, Inc. | 1 | $95 |
| Sight Sciences, Inc. | 1 | $94 |
| Oyster Point Pharma, Inc. | 1 | $74 |
| AbbVie | 1 | $35 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MyDay Contact Lens$49,379
- Clariti Contact Lens$7,682
- Biofinity Contact Lens$3,172
- Non-Product Brand Specific$1,000
- Clareon$369
- Multiple Brands Contact Lens$309
- INFUSE$237
- XIIDRA$227
- VABYSMO$147
- Syfovre$145
- MiSight Contact Lens$124
- VEVYE$123
- CEQUA$115
- MIEBO$102
How this compares
$74,564 in reported general payments places this provider in the 95th percentile of 712 optometrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 92 | $792 |
| Prednisolone Acetate | 17 | $544 |
| Timolol Maleate | 30 | $223 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $148 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Calvert City
- Paul KarpeckiLexington$3.6M
- Bilal AhmadLexington$150K
- Clay MattsonNicholasville$93K
- Lee PeplinskiLouisville$74K
- Austin LifferthLouisville$72K
- Christopher KucLexington$52K
- Kristine Kerestan GarbigWilder$51K
- Renee ReederPikeville$27K
- Karoline MunsonFrankfort$26K
- Aaron McNultyLouisville$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.